FDA Inspection 1265731 — Hilda A. Mujuru
The FDA completed an inspection of Hilda A. Mujuru on Mar 21, 2025 in Harare. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Harare (Zimbabwe)
Additional details
Clinical BA/BE